The resolution recognizes amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, as a progressive and fatal neurodegenerative condition that severely impacts a person's ability to perform basic functions such as walking, talking, and breathing. It highlights the alarming statistics surrounding ALS, including the frequency of new diagnoses and deaths, the average survival time post-diagnosis, and the lack of known causes or cures. The resolution also notes the increased risk of ALS among military veterans and emphasizes the importance of access to therapies, medical equipment, and communication technologies for those living with the disease.

In light of these issues, the resolution proclaims May 2026 as ALS Awareness Month in Missouri, aiming to raise public awareness about the challenges faced by individuals with ALS and their families. It calls for support of ALS research and advocacy for increased funding to combat the disease. The resolution acknowledges the significant contributions of the ALS Association, which has invested over $154 million in research projects globally, and encourages all Americans to stand in solidarity with those affected by ALS.